List of Excipients in API erlotinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing erlotinib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | CELLULOSE, MICROCRYSTALLINE | |
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | FD&C YELLOW NO. 6 | |
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | HYDROXYPROPYL CELLULOSE | |
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | HYPROMELLOSES | |
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | LACTOSE MONOHYDRATE | |
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | MAGNESIUM STEARATE | |
| Physicians Total Care Inc | TARCEVA | erlotinib hydrochloride | 54868-5290 | SODIUM LAURYL SULFATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing erlotinib
Detailed excipient profiles for erlotinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
erlotinib drug variants containing CELLULOSE, MICROCRYSTALLINE
erlotinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| Mylan Pharmaceuticals Inc | erlotinib hydrochloride | 0378-7131 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
erlotinib drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing CROSPOVIDONE
Excipient focus: FD&C YELLOW NO. 6
erlotinib drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | erlotinib hydrochloride | 54868-5290 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROXYPROPYL CELLULOSE
erlotinib drug variants containing HYDROXYPROPYL CELLULOSE
erlotinib drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
erlotinib drug variants containing HYPROMELLOSE
erlotinib drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
erlotinib drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
erlotinib drug variants containing HYPROMELLOSE 2910
erlotinib drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
erlotinib drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | erlotinib hydrochloride | 54868-5290 |
| MSN LABORATORIES PRIVATE LIMITED | erlotinib hydrochloride | 69539-090 |
| Novadoz Pharmaceuticals LLC | erlotinib hydrochloride | 72205-080 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
erlotinib drug variants containing LACTOSE MONOHYDRATE
erlotinib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
erlotinib drug variants containing MAGNESIUM STEARATE
erlotinib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
erlotinib drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
erlotinib drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | erlotinib | 59651-530 |
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| Mylan Pharmaceuticals Inc | erlotinib hydrochloride | 0378-7131 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
erlotinib drug variants containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | erlotinib | 31722-263 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Excipient focus: POLYDEXTROSE
erlotinib drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
erlotinib drug variants containing POLYETHYLENE GLYCOL
erlotinib drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
erlotinib drug variants containing POLYETHYLENE GLYCOL 400
erlotinib drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
erlotinib drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
erlotinib drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: PROPYLENE GLYCOL
erlotinib drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| MSN LABORATORIES PRIVATE LIMITED | erlotinib hydrochloride | 69539-090 |
| Novadoz Pharmaceuticals LLC | erlotinib hydrochloride | 72205-080 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
erlotinib drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
| Aurobindo Pharma Limited | erlotinib | 59651-530 |
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
erlotinib drug variants containing SODIUM LAURYL SULFATE
erlotinib drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
erlotinib drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
erlotinib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
erlotinib drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | erlotinib hydrochloride | 51991-890 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
erlotinib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | erlotinib | 63304-095 |
| Zydus Pharmaceuticals USA Inc | erlotinib | 68382-913 |
| Cadila Healthcare Limited | erlotinib | 70771-1521 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
erlotinib drug variants containing TITANIUM DIOXIDE
erlotinib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
erlotinib drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7662 |
| Teva Pharmaceuticals USA Inc | erlotinib | 0093-7663 |
| >Company | >Ingredient | >NDC |
erlotinib drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
